Your GO-2 for wounds of all sizes and complexities
A duo with proven cellular and/or tissue-based products (CTP) for all wound sizes, payers and clinical needs. All from a single, trusted leader in wound care.
GO for size
Wounds of various sizes and complexities.
GO for coverage
Reimbursed across most payers at a high value to you.
GO for composition
Retains components that closely mimic human skin.
GO for efficacy
Close more wounds faster than leading competitors in a clinical setting.
GRAFIX Membrane + OASIS Matrix
Your GO-2 for all your CTP needs
One CTP does not fit all, but one CTP duo does
Both available off the shelf in a wide variety of shapes and sizes to manage complex wounds.
GRAFIX Membrane ideal for wounds up to 25 cm2
- Carefully processed to minimize manipulation
- All native components preserved, including native placental cells
- Stored at room temperature
OASIS Matrix Products ideal for wounds > 25 cm2 – with high and low-bundle options
- Naturally derived scaffolds of ECM of porcine small intestinal submucosa (SIS)20
- Supports the body’s own tissue repair mechanisms by providing pathways to cellular migration and vascular growth24
- Available in one-, two-, and three-layer options for acute and chronic wounds and burns
- OASIS Burn (two-layer) is a high-bundle CTP
OASIS is derived from a porcine source and should not be used in patients with known sensitivity to porcine material. See the Instructions for Use for more information.
Both GRAFIX and OASIS are stored at room temperature and ready off the shelf.
A versatile, effective duo in the OR and outpatient wound clinic
More than 10% of wounds seen in the OR and outpatient wound clinic are larger than 25cm2 but many haven’t been considered good candidates for CTP treatment. Until now. Both GRAFIX Membrane and OASIS Matrix are:
- Easy to work with
- Proven more effective than leading competitors11,18
- Excellent shelf life
GRAFIX Membrane
With a 62% heal rate at 12 weeks with 2 applications, GRAFIX has consistently had the highest overall efficacy vs. standard care and was the only dermal substitute determined to have “high quality evidence.”11
OASIS Matrix
Shown to achieve greater effectiveness in the management of chronic leg ulcers and diabetic foot ulcers, achieving improved epithelialization and wound closure compared to standard care alone.18,19
Your GO-2 for broad coverage across national payers and Medicare
- Medicare at 100%
- 50 out of the top 50 payers for DFUs
- 42 out of the top 50 payers for VLUs
| Payer Name | GRAFIX and GRAFIX PL Membrane (Q4133) | GRAFIX Core Membrane (Q4132) | OASIS Wound Matrix (Q4102) | OASIS Burn Matrix (Q4103) | OASIS ULTRA Matrix (Q4124) |
|---|---|---|---|---|---|
 |
DFU | Not covered | Based on medical necessity | Based on medical necessity | Based on medical necessity |
 |
DFU * PRIME only | Not covered | Lower extremity dermal wounds | Not covered | Lower extremity dermal wounds |
 |
DFU | DFU | DFU, VLU | Not covered | Not covered |
 Includes HealthNet |
DFU, VLU, VSU | DFU, VLU, VSU | DFU, VLU, VSU 2nd degree burns |
DFU, VLU, VSU 2nd degree burns |
DFU, VLU, VSU 2nd degree burns |
 TX, OK, IL, NM, MT |
DLEU | DLEU | VLU | Not covered | Not covered |
 |
DFU, VSU | DFU, VSU | DFU, VSU | Not covered | DFU, VSU |
 |
DFU | DFU | DLEU, VLU | Not covered | DLEU, VLU |
 No policy (exception WA state) |
Not on contract | Not on contract | Based on medical neccesity† | Not covered | Based on medical neccesity† |
 |
DLEU | DLEU | VLU | Not covered | Not covered |
 |
DFU, VLU | DFU, VLU | DFU, VLU, VSU, Burns |
DFU, VLU, VSU, Burns |
DFU, VLU, VSU, Burns |
DFU = Diabetic Foot Ulcer
DLEU = Diabetic Lower Extremity Ulcer
VLU = Venous Leg Ulcer
VSU = Venous Stasis Ulcer
Policy Numbers
United: 2022T0592K
Anthem: Surg.00011
Aetna: 0244
Centene: CP.MP.185
HCSC BCBS Plans: SUR704.011 (for Amniotic Only), SUR704.012 (for Bioengineered)
Policy Numbers
Cigna: 0068
Humana: HCS-0370-046
FEP BCBS: 7.01.149 (for Amniotic Only), 7.01.113 (for Bioengineered)
Molina Healthcare Management Medicaid: MCP-357
Updated February 2023
†DFU, VLU for WA state
Your GO-2 for better results and more predictable outcomes
Our CTP duo versus Apligraf and PuraPly AM in the treatment of Diabetic Foot Ulcers:
GRAFIX Membrane
2x
faster median time to DFU closure than Apligraf
(in an RCT setting)
As shown in separate clinical trials6,21
OASIS ULTRA Tri-layer Matrix
2.6x
faster median time to DFU closure than PuraPly AM
As shown in separate clinical trials22
Our CTP portfolio versus EpiFix
GRAFIX Membrane
3x
more wounds closed than EpiFix11
Showing comparable results, OASIS Matrix Products are more than
8.5x
less expensive than EpiFix.*
*Based on Average Selling Prices (ASP) of 30cm2 and 35cm2 sizes of Epifix and OASIS Matrix Products, respectively. EpiFix ASP data obtained from ECRI, January 2023.
Tell me more about GRAFIX Placental Membrane Products and OASIS Matrix Products
Go for more: download our clinical studies
